Gilder Gagnon Howe & Co. LLC Has $85.15 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Gilder Gagnon Howe & Co. LLC boosted its position in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 51.4% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 6,335,862 shares of the company's stock after purchasing an additional 2,151,256 shares during the period. Gilder Gagnon Howe & Co. LLC owned about 2.56% of Oscar Health worth $85,154,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. JPMorgan Chase & Co. increased its holdings in shares of Oscar Health by 348.7% during the 4th quarter. JPMorgan Chase & Co. now owns 10,360,529 shares of the company's stock worth $139,246,000 after acquiring an additional 8,051,379 shares during the last quarter. BIT Capital GmbH raised its holdings in Oscar Health by 5,711.6% in the 4th quarter. BIT Capital GmbH now owns 4,473,853 shares of the company's stock valued at $60,129,000 after acquiring an additional 4,396,872 shares during the period. Hennessy Advisors Inc. grew its position in shares of Oscar Health by 550.3% in the fourth quarter. Hennessy Advisors Inc. now owns 4,188,400 shares of the company's stock valued at $56,292,000 after purchasing an additional 3,544,300 shares during the last quarter. Clearbridge Investments LLC acquired a new stake in Oscar Health during the 4th quarter worth approximately $19,088,000. Finally, American Century Companies Inc. increased its position in Oscar Health by 185.6% during the 4th quarter. American Century Companies Inc. now owns 1,285,204 shares of the company's stock worth $17,273,000 after buying an additional 835,144 shares during the period. Institutional investors own 75.70% of the company's stock.

Oscar Health Trading Up 0.8 %

Shares of OSCR stock traded up $0.11 during trading hours on Thursday, hitting $13.12. 1,640,154 shares of the company's stock traded hands, compared to its average volume of 3,905,897. The stock has a market cap of $3.29 billion, a PE ratio of -654.07 and a beta of 1.75. The stock's 50 day simple moving average is $13.40 and its 200 day simple moving average is $14.74. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing the consensus estimate of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 EPS for the current year.

Wall Street Analyst Weigh In

Separately, Wells Fargo & Company lowered shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the stock from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, three have given a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and an average target price of $20.21.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.